http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012521404-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-3156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-095 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-39 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-74 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-09 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-04 |
| filingDate | 2010-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2012521404-A |
| titleOfInvention | Combinations containing pneumococcal serotype 14 sugars |
| abstract | Neisseria meningitidis lipooligosaccharide and pneumococcal serotype 14 capsular saccharide share an antigen that can cross-react with human tissue. The present invention provides various methods for minimizing the production of autoreactive antibodies when these two antigens are co-administered. In one aspect, the present invention provides an immunogenic composition comprising meningococcal lipooligosaccharide (LOS) and pneumococcal serotype 14 capsular saccharide (CS14), wherein the LOS and / or CS14 is Does not contain Galβ1-4GlcNAcβ1-3Galβ1-4Glc tetrasaccharide. |
| priorityDate | 2009-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 324.